Danaher Corporation $DHR Holdings Increased by 11 Capital Partners LP

11 Capital Partners LP grew its position in shares of Danaher Corporation (NYSE:DHR) by 78.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 105,300 shares of the conglomerate’s stock after purchasing an additional 46,200 shares during the period. Danaher makes up 5.9% of 11 Capital Partners LP’s portfolio, making the stock its 6th biggest holding. 11 Capital Partners LP’s holdings in Danaher were worth $20,877,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. WFA of San Diego LLC purchased a new stake in shares of Danaher during the 2nd quarter valued at $26,000. Howard Hughes Medical Institute bought a new position in shares of Danaher during the 2nd quarter valued at about $27,000. ANTIPODES PARTNERS Ltd purchased a new position in shares of Danaher during the 3rd quarter valued at about $27,000. TruNorth Capital Management LLC purchased a new position in shares of Danaher during the 3rd quarter valued at about $28,000. Finally, Tripletail Wealth Management LLC bought a new stake in Danaher in the 3rd quarter worth approximately $31,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Danaher stock opened at $186.39 on Friday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $242.80. The stock’s 50 day simple moving average is $219.65 and its two-hundred day simple moving average is $215.49. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The stock has a market cap of $131.81 billion, a price-to-earnings ratio of 36.98, a PEG ratio of 2.63 and a beta of 0.93.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. During the same quarter last year, the business posted $2.14 EPS. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. As a group, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be paid a dividend of $0.40 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, March 27th. Danaher’s payout ratio is 25.40%.

Insider Buying and Selling at Danaher

In other news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the transaction, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on DHR shares. JPMorgan Chase & Co. increased their price target on shares of Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday, January 29th. Jefferies Financial Group increased their target price on shares of Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research note on Monday, December 29th. Morgan Stanley began coverage on shares of Danaher in a research report on Monday, December 1st. They set an “overweight” rating and a $270.00 price target for the company. Finally, Leerink Partners lifted their price objective on Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a report on Friday, January 16th. Twenty research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $253.86.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.